Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: May 2001 June 25, 2001
Flooding Angiogenic Molecule Into Tumor Patients May Cause Dire, But Reversible, Defect June 21, 2001
RSS